Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Pharma & Healthcare
Published Date: 2025-09-11
Pages: 132 Pages
Report ld: 5038473
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2025-2031
-3.23%
Market Size,2031
USD 2.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2.8 million
Market Forecast in 2031(Value)
US$ 2.3 million
CAGR
-3.23%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Octreotide market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Octreotide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Octreotide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Octreotide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market Segmentation by Application
1.3.1 Global Octreotide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Octreotide Revenue Estimates and Forecasts 2020-2031
2.2 Global Octreotide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Octreotide Sales Estimates and Forecasts 2020-2031
2.4 Global Octreotide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Octreotide Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Octreotide Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Octreotide Injection Market Size by Manufacturers
3.5.2 Octreotide Powder Market Size by Manufacturers
3.5.3 Octreotide Microspheres Market Size by Manufacturers
3.6 Global Octreotide Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Octreotide Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Octreotide Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Octreotide Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Octreotide Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Octreotide Sales and Revenue by Type (2020-2031)
6.4 North America Octreotide Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Octreotide Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Octreotide Sales and Revenue by Type (2020-2031)
7.4 Europe Octreotide Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Octreotide Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Octreotide Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Octreotide Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Octreotide Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Octreotide Sales and Revenue by Type (2020-2031)
9.4 Central and South America Octreotide Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Octreotide Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Octreotide Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Octreotide Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Octreotide Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview
11.1.3 Novartis Octreotide Product Models, Descriptions and Specifications
11.1.4 Novartis Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Novartis Octreotide Sales by Product in 2024
11.1.6 Novartis Octreotide Sales by Application in 2024
11.1.7 Novartis Octreotide Sales by Geographic Area in 2024
11.1.8 Novartis Octreotide SWOT Analysis
11.1.9 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Corporation Information
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Octreotide Product Models, Descriptions and Specifications
11.2.4 Sun Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Sun Pharmaceutical Octreotide Sales by Product in 2024
11.2.6 Sun Pharmaceutical Octreotide Sales by Application in 2024
11.2.7 Sun Pharmaceutical Octreotide Sales by Geographic Area in 2024
11.2.8 Sun Pharmaceutical Octreotide SWOT Analysis
11.2.9 Sun Pharmaceutical Recent Developments
11.3 Chengdu Tiantaishan pharmaceutical
11.3.1 Chengdu Tiantaishan pharmaceutical Corporation Information
11.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
11.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Product Models, Descriptions and Specifications
11.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Product in 2024
11.3.6 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Application in 2024
11.3.7 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Geographic Area in 2024
11.3.8 Chengdu Tiantaishan pharmaceutical Octreotide SWOT Analysis
11.3.9 Chengdu Tiantaishan pharmaceutical Recent Developments
11.4 Sinopharm A-Think Pharmaceuticals
11.4.1 Sinopharm A-Think Pharmaceuticals Corporation Information
11.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
11.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Product Models, Descriptions and Specifications
11.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Product in 2024
11.4.6 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Application in 2024
11.4.7 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Geographic Area in 2024
11.4.8 Sinopharm A-Think Pharmaceuticals Octreotide SWOT Analysis
11.4.9 Sinopharm A-Think Pharmaceuticals Recent Developments
11.5 Sihuan Pharmaceutical Holdings Group
11.5.1 Sihuan Pharmaceutical Holdings Group Corporation Information
11.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
11.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Product Models, Descriptions and Specifications
11.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Product in 2024
11.5.6 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Application in 2024
11.5.7 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Geographic Area in 2024
11.5.8 Sihuan Pharmaceutical Holdings Group Octreotide SWOT Analysis
11.5.9 Sihuan Pharmaceutical Holdings Group Recent Developments
11.6 Shanghai Soho-Yiming Pharmaceuticals
11.6.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
11.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
11.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Models, Descriptions and Specifications
11.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
11.7 Yibin Pharmaceutical
11.7.1 Yibin Pharmaceutical Corporation Information
11.7.2 Yibin Pharmaceutical Business Overview
11.7.3 Yibin Pharmaceutical Octreotide Product Models, Descriptions and Specifications
11.7.4 Yibin Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Yibin Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Octreotide Industry Chain
12.2 Octreotide Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Octreotide Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Octreotide Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Octreotide Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Octreotide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Octreotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Octreotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Octreotide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Octreotide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Octreotide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Gram)
Table 7. Global Octreotide Sales by Region (2020-2025) & (Gram)
Table 8. Global Octreotide Sales by Region (2026-2031) & (Gram)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Octreotide Sales by Manufacturers (2020-2025) & (Gram)
Table 11. Global Octreotide Sales Share by Manufacturers (2020-2025)
Table 12. Global Octreotide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Octreotide Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Octreotide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
Table 16. Global Octreotide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Octreotide Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Gram)
Table 18. Key Manufacturers Octreotide Manufacturing Base and Headquarters
Table 19. Global Octreotide Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Octreotide Sales by Type (2020-2025) & (Gram)
Table 23. Global Octreotide Sales by Type (2026-2031) & (Gram)
Table 24. Global Octreotide Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Octreotide Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Octreotide ASP by Type (2020-2031) & (USD/Gram)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Octreotide Sales by Application (2020-2025) & (Gram)
Table 29. Global Octreotide Sales by Application (2026-2031) & (Gram)
Table 30. Octreotide High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Octreotide Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Octreotide Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Octreotide ASP by Application (2020-2031) & (USD/Gram)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Octreotide Growth Accelerators and Market Barriers
Table 37. North America Octreotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Octreotide Sales (Gram) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Octreotide Growth Accelerators and Market Barriers
Table 40. Europe Octreotide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Octreotide Sales (Gram) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Octreotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Octreotide Sales (Gram) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Octreotide Growth Accelerators and Market Barriers
Table 45. Southeast Asia Octreotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Octreotide Investment Opportunities and Key Challenges
Table 47. Central and South America Octreotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Octreotide Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Octreotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Novartis Corporation Information
Table 51. Novartis Description and Major Businesses
Table 52. Novartis Product Models, Descriptions and Specifications
Table 53. Novartis Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 54. Novartis Sales Value Proportion by Product in 2024
Table 55. Novartis Sales Value Proportion by Application in 2024
Table 56. Novartis Sales Value Proportion by Geographic Area in 2024
Table 57. Novartis Octreotide SWOT Analysis
Table 58. Novartis Recent Developments
Table 59. Sun Pharmaceutical Corporation Information
Table 60. Sun Pharmaceutical Description and Major Businesses
Table 61. Sun Pharmaceutical Product Models, Descriptions and Specifications
Table 62. Sun Pharmaceutical Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 63. Sun Pharmaceutical Sales Value Proportion by Product in 2024
Table 64. Sun Pharmaceutical Sales Value Proportion by Application in 2024
Table 65. Sun Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 66. Sun Pharmaceutical Octreotide SWOT Analysis
Table 67. Sun Pharmaceutical Recent Developments
Table 68. Chengdu Tiantaishan pharmaceutical Corporation Information
Table 69. Chengdu Tiantaishan pharmaceutical Description and Major Businesses
Table 70. Chengdu Tiantaishan pharmaceutical Product Models, Descriptions and Specifications
Table 71. Chengdu Tiantaishan pharmaceutical Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 72. Chengdu Tiantaishan pharmaceutical Sales Value Proportion by Product in 2024
Table 73. Chengdu Tiantaishan pharmaceutical Sales Value Proportion by Application in 2024
Table 74. Chengdu Tiantaishan pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 75. Chengdu Tiantaishan pharmaceutical Octreotide SWOT Analysis
Table 76. Chengdu Tiantaishan pharmaceutical Recent Developments
Table 77. Sinopharm A-Think Pharmaceuticals Corporation Information
Table 78. Sinopharm A-Think Pharmaceuticals Description and Major Businesses
Table 79. Sinopharm A-Think Pharmaceuticals Product Models, Descriptions and Specifications
Table 80. Sinopharm A-Think Pharmaceuticals Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 81. Sinopharm A-Think Pharmaceuticals Sales Value Proportion by Product in 2024
Table 82. Sinopharm A-Think Pharmaceuticals Sales Value Proportion by Application in 2024
Table 83. Sinopharm A-Think Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 84. Sinopharm A-Think Pharmaceuticals Octreotide SWOT Analysis
Table 85. Sinopharm A-Think Pharmaceuticals Recent Developments
Table 86. Sihuan Pharmaceutical Holdings Group Corporation Information
Table 87. Sihuan Pharmaceutical Holdings Group Description and Major Businesses
Table 88. Sihuan Pharmaceutical Holdings Group Product Models, Descriptions and Specifications
Table 89. Sihuan Pharmaceutical Holdings Group Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 90. Sihuan Pharmaceutical Holdings Group Sales Value Proportion by Product in 2024
Table 91. Sihuan Pharmaceutical Holdings Group Sales Value Proportion by Application in 2024
Table 92. Sihuan Pharmaceutical Holdings Group Sales Value Proportion by Geographic Area in 2024
Table 93. Sihuan Pharmaceutical Holdings Group Octreotide SWOT Analysis
Table 94. Sihuan Pharmaceutical Holdings Group Recent Developments
Table 95. Shanghai Soho-Yiming Pharmaceuticals Corporation Information
Table 96. Shanghai Soho-Yiming Pharmaceuticals Description and Major Businesses
Table 97. Shanghai Soho-Yiming Pharmaceuticals Product Models, Descriptions and Specifications
Table 98. Shanghai Soho-Yiming Pharmaceuticals Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 99. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
Table 100. Yibin Pharmaceutical Corporation Information
Table 101. Yibin Pharmaceutical Description and Major Businesses
Table 102. Yibin Pharmaceutical Product Models, Descriptions and Specifications
Table 103. Yibin Pharmaceutical Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 104. Yibin Pharmaceutical Recent Developments
Table 105. Key Raw Materials Distribution
Table 106. Raw Materials Key Suppliers
Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 108. Milestones in Production Technology Evolution
Table 109. Distributors List
Table 110. Market Trends and Market Evolution
Table 111. Market Drivers and Opportunities
Table 112. Market Challenges, Risks, and Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Octreotide Injection Product Picture
Figure 4. Octreotide Powder Product Picture
Figure 5. Octreotide Microspheres Product Picture
Figure 6. Global Octreotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Treating Severe Diarrhea
Figure 8. Treating Acromegaly
Figure 9. Others
Figure 10. Octreotide Report Years Considered
Figure 11. Global Octreotide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Octreotide Revenue (2020-2031) & (US$ Million)
Figure 13. Global Octreotide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Octreotide Revenue Market Share by Region (2020-2031)
Figure 15. Global Octreotide Sales (2020-2031) & (Gram)
Figure 16. Global Octreotide Sales (CAGR) by Region (2020-2031) (Gram)
Figure 17. Global Octreotide Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Octreotide Sales Volume Market Share in 2024
Figure 19. Global Octreotide Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Octreotide Injection Revenue Market Share by Manufacturer in 2024
Figure 22. Octreotide Powder Revenue Market Share by Manufacturer in 2024
Figure 23. Octreotide Microspheres Revenue Market Share by Manufacturer in 2024
Figure 24. Global Octreotide Sales Market Share by Type (2020-2031)
Figure 25. Global Octreotide Revenue Market Share by Type (2020-2031)
Figure 26. Global Octreotide Sales Market Share by Application (2020-2031)
Figure 27. Global Octreotide Revenue Market Share by Application (2020-2031)
Figure 28. North America Octreotide Sales YoY (2020-2031) & (Gram)
Figure 29. North America Octreotide Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Octreotide Sales Revenue (US$ Million) in 2024
Figure 31. North America Octreotide Sales Volume (Gram) by Type (2020- 2031)
Figure 32. North America Octreotide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Octreotide Sales Volume (Gram) by Application (2020-2031)
Figure 34. North America Octreotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Octreotide Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Octreotide Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Octreotide Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Octreotide Sales YoY (2020-2031) & (Gram)
Figure 39. Europe Octreotide Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Octreotide Sales Revenue (US$ Million) in 2024
Figure 41. Europe Octreotide Sales Volume (Gram) by Type (2020-2031)
Figure 42. Europe Octreotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Octreotide Sales Volume (Gram) by Application (2020-2031)
Figure 44. Europe Octreotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Octreotide Revenue (2020-2031) & (US$ Million)
Figure 46. France Octreotide Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Octreotide Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Octreotide Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Octreotide Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Octreotide Sales YoY (2020-2031) & (Gram)
Figure 51. Asia-Pacific Octreotide Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Octreotide Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Octreotide Sales Volume (Gram) by Type (2020- 2031)
Figure 54. Asia-Pacific Octreotide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Octreotide Sales Volume (Gram) by Application (2020-2031)
Figure 56. Asia-Pacific Octreotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Octreotide Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Octreotide Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Octreotide Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Octreotide Revenue (2020-2031) & (US$ Million)
Figure 61. India Octreotide Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Octreotide Sales YoY (2020-2031) & (Gram)
Figure 63. Central and South America Octreotide Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Octreotide Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Octreotide Sales Volume (Gram) by Type (2021-2031)
Figure 66. Central and South America Octreotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Octreotide Sales Volume (Gram) by Application (2020-2031)
Figure 68. Central and South America Octreotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Octreotide Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Octreotide Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Octreotide Sales YoY (2020-2031) & (Gram)
Figure 72. Middle East and Africa Octreotide Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Octreotide Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Octreotide Sales Volume (Gram) by Type (2021-2031)
Figure 75. South America Octreotide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Octreotide Sales Volume (Gram) by Application (2020-2031)
Figure 77. Middle East and Africa Octreotide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Octreotide Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Octreotide Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Octreotide Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Octreotide Revenue (2020-2025) & (US$ Million)
Figure 82. Octreotide Industry Chain Mapping
Figure 83. Regional Octreotide Manufacturing Base Distribution (%)
Figure 84. Global Octreotide Production Market Share by Region (2020-2031)
Figure 85. Octreotide Production Process
Figure 86. Regional Octreotide Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Octreotide in 2025?
The global market size of Octreotide in 2025 was 2.8 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Octreotide in 2031?
What is the annual compound growth rate of the global Octreotide market size from 2025 to 2031?
Which companies rank high in the global Octreotide market?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now